Journal
ALZHEIMERS RESEARCH & THERAPY
Volume 2, Issue 6, Pages -Publisher
BMC
DOI: 10.1186/alzrt58
Keywords
-
Categories
Funding
- NIA [AG016570, P30AG10124]
- Sidell-Kagan Foundation
- Marian S. Ware Alzheimer Program
Ask authors/readers for more resources
Among the key challenges in Alzheimer's disease drug development is the timely completion of clinical trials. Unfortunately, clinical trials often suffer from slow or insufficient enrollment. Successful clinical trial recruitment describes a balance between expeditiously achieving full enrollment and ensuring an appropriate study sample. Investigators face a number of challenges to the successful negotiation of this balance. The failure to address these challenges means that drug development may take more time and money and that trial results may not adequately represent drug efficacy or may not be applicable beyond the study. We review the challenges to recruitment and retention in Alzheimer's disease clinical trials and present a framework to address them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available